Carcinogenesis, Teratogenesis & Mutagenesis ›› 2003, Vol. 15 ›› Issue (1): 32-34.doi: 10.3969/j.issn.1004-616x.2003.01.009

Previous Articles     Next Articles

MUTAGENICITY RESEARCH OF No.Ⅱ DRUG

LIU Xiao-qiu, WANG Rong-xian, TIAN Qing-wei   

  1. Institute of Radiation Medicine Chinese Academy of Medical Sciences, Tianjin 300192 , China
  • Received:2002-05-31 Revised:2002-07-22 Online:2003-01-30 Published:2003-01-30
  • Contact: LIU Xiao-qiu

Abstract: Purpose and methods: The mutagenicity of No.Ⅱdrug was examined using Ames test, CHO-K cell chromosome aberration test and micronucleus test. Results: No.Ⅱ drug in the dose range of 1~5 000 μg / plate did not increase the number of reversion mutation in any of the 4 strains with or without S 9 in Ames test. The frequencies of micronuclear cell(MNCF) in PCE did not increase with dose of 25~125 mg / kg in micronucleus test. In CHO-K cell chromosome aberration test, the result was suspiciously positive because the frequency of chromosome aberration increased to 8 % with the dose of 250 μg / ml with S 9. Conclusion: The results of No.Ⅱ drug in Ames test and micronucleus test were negative, and at higher dose in chromosome aberration test the result was suspiciously positive.

Key words: No.Ⅱ drug, Ames test, Micronucleus, Chromosome aberration